Warberg Asset Management »

Protagenic Therapeutics shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Protagenic Therapeutics (PTIXW) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Protagenic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1k 177k 0.01
2024-06-30 $1.5k 177k 0.01
2024-03-31 $5.7k 177k 0.03
2023-12-31 $1.6k 177k 0.01
2023-09-30 $5.3k 177k 0.03
2023-06-30 $5.9k 177k 0.03
2023-03-31 $4.3k 177k 0.02
2022-12-31 $7.3k 177k 0.04
2022-09-30 $12k 286k 0.04
2022-06-30 $49k 328k 0.15
2022-03-31 $78k 362k 0.22
2021-12-31 $69k 182k 0.38
2021-09-30 $143k 365k 0.39
2021-06-30 $260k 366k 0.71

Top funds holding Protagenic Therapeutics